Last reviewed · How we verify

NCT03407677: ROTOone

The Impact of ROTO Track® in Helping Patients With Diabetes Rotate Their Insulin Injections Better

Completed NA Last updated 3 March 2021
What this trial tests

NA trial testing ROTO track® in Diabetes in 35 participants. Completed in 27 November 2019.

Timeline
27 August 2018
Primary endpoint
20 November 2019
27 November 2019

Quick facts

Lead sponsorPeter Lommer
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment35
Start date27 August 2018
Primary completion20 November 2019
Estimated completion27 November 2019
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Peter Lommer

Who can join

18 and older, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ROTO track® is an electronic injection form and injection log for keeping track of injection sites in the abdominal region. The device attaches directly to the insulin pen and activates whenever the insulin pen is picked up. Small LED lights on the device will indicate where the next injection site is according to the individual patient's injection plan. By moving the pen and device to an "anchor point" in front of the navel, the device is able to start tracking where the insulin pen is being moved to. The device additionally contains a haptic interface to indicate to the user when the device has been moved to the next area in the injection plan. The device registers the location, the time and the dosage automatically when the patient injects insulin with the pen The rationale of the trial is that the ROTO track® can help patients rotate their injections sites and that this will provide the healthcare system with a new cost-effective tool for improving insulin injection techniques.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. 56<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : 21-25 September 2020.
    · 2020 · cited 9× · PMID 32840677 · DOI 10.1007/s00125-020-05221-5
  2. A New Medical Device for Improved Rotation of Insulin Injections in Type 1 Diabetes Mellitus: A Proof-of-Concept Study.
    Klarskov CK, Hamid YH, Tjalk-Bøggild R, Tarnow L, et al · · 2021 · cited 4× · PMID 32830524 · DOI 10.1177/1932296820950688

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03407677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing